140 related articles for article (PubMed ID: 1328099)
1. Design of chimeric peptide ligands to galanin receptors and substance P receptors.
Langel U; Land T; Bartfai T
Int J Pept Protein Res; 1992 Jun; 39(6):516-22. PubMed ID: 1328099
[TBL] [Abstract][Full Text] [Related]
2. Galanin receptors in human basal forebrain differ from receptors in the hypothalamus: characterization using [125I]galanin (porcine) and [125I]galantide.
Deecher DC; Odusan OO; Mufson EJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):720-7. PubMed ID: 7473159
[TBL] [Abstract][Full Text] [Related]
3. Solution structure by 2D 1H-NMR of a chimeric peptide recognized by galanin and neuropeptide Y receptors.
Arvidsson K; Land T; Langel U; Bartfai T; Ehrenberg A
Biochemistry; 1993 Aug; 32(30):7787-98. PubMed ID: 7688568
[TBL] [Abstract][Full Text] [Related]
4. Linear and cyclic N-terminal galanin fragments and analogs as ligands at the hypothalamic galanin receptor.
Land T; Langel U; Löw M; Berthold M; Undén A; Bartfai T
Int J Pept Protein Res; 1991 Sep; 38(3):267-72. PubMed ID: 1722197
[TBL] [Abstract][Full Text] [Related]
5. New high affinity peptide antagonists to the spinal galanin receptor.
Xu XJ; Wiesenfeld-Hallin Z; Langel U; Bedecs K; Bartfai T
Br J Pharmacol; 1995 Oct; 116(3):2076-80. PubMed ID: 8640348
[TBL] [Abstract][Full Text] [Related]
6. Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types.
Kahl U; Langel U; Bartfai T; Grundemar L
Br J Pharmacol; 1994 Apr; 111(4):1129-34. PubMed ID: 7518295
[TBL] [Abstract][Full Text] [Related]
7. Galanin receptors in human hypothalamus: biochemical and structural analysis.
Lorinet AM; Javoy-Agid F; Laburthe M; Amiranoff B
Eur J Pharmacol; 1994 Sep; 269(1):59-64. PubMed ID: 7530206
[TBL] [Abstract][Full Text] [Related]
8. Galanin receptor antagonists M40 and C7 block galanin-induced feeding.
Crawley JN; Robinson JK; Langel U; Bartfai T
Brain Res; 1993 Jan; 600(2):268-72. PubMed ID: 7679604
[TBL] [Abstract][Full Text] [Related]
9. Role of galanin in stimulation of pituitary luteinizing hormone secretion as revealed by a specific receptor antagonist, galantide.
Sahu A; Xu B; Kalra SP
Endocrinology; 1994 Feb; 134(2):529-36. PubMed ID: 7507825
[TBL] [Abstract][Full Text] [Related]
10. Galantide distinguishes putative subtypes of galanin receptors in mudpuppy parasympathetic neurons.
Mulvaney JM; Merriam LA; Parsons RL
Eur J Pharmacol; 1995 Dec; 287(1):97-100. PubMed ID: 8666034
[TBL] [Abstract][Full Text] [Related]
11. A galanin-mastoparan chimeric peptide activates the Na+,K(+)-ATPase and reverses its inhibition by ouabain.
Langel U; Pooga M; Kairane C; Zilmer M; Bartfai T
Regul Pept; 1996 Apr; 62(1):47-52. PubMed ID: 8738882
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor.
Wynick D; Smith DM; Ghatei M; Akinsanya K; Bhogal R; Purkiss P; Byfield P; Yanaihara N; Bloom SR
Proc Natl Acad Sci U S A; 1993 May; 90(9):4231-5. PubMed ID: 7683428
[TBL] [Abstract][Full Text] [Related]
13. Spinal antinociception by morphine in rats is antagonised by galanin receptor antagonists.
Reimann W; Englberger W; Friderichs E; Selve N; Wilffert B
Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):380-6. PubMed ID: 7531294
[TBL] [Abstract][Full Text] [Related]
14. The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion.
Lindskog S; Ahrén B; Land T; Langel U; Bartfai T
Eur J Pharmacol; 1992 Jan; 210(2):183-8. PubMed ID: 1376272
[TBL] [Abstract][Full Text] [Related]
15. Analogs of galanin (1-16) modified in positions 1-3 as ligands to rat hypothalamic galanin receptors.
Rivera Baeza C; Kask K; Langel U; Bartfai T; Undén A
Acta Chem Scand (Cph); 1994 May; 48(5):434-8. PubMed ID: 8018437
[TBL] [Abstract][Full Text] [Related]
16. Binding and agonist/antagonist actions of M35, galanin(1-13)-bradykinin(2-9)amide chimeric peptide, in Rin m 5F insulinoma cells.
Kask K; Berthold M; Bourne J; Andell S; Langel U; Bartfai T
Regul Pept; 1995 Nov; 59(3):341-8. PubMed ID: 8577939
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological properties of new chimeric galanin analogue GAL(1-13)-[Ala10,11]ET-1(6-21)-NH2.
Ruczyński J; Konstański Z; Cybal M; Petrusewicz J; Wójcikowski C; Rekowski P; Kamińska B
J Physiol Pharmacol; 2005 Jun; 56(2):273-85. PubMed ID: 15985708
[TBL] [Abstract][Full Text] [Related]
18. M-15: high-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord.
Bartfai T; Bedecs K; Land T; Langel U; Bertorelli R; Girotti P; Consolo S; Xu XJ; Wiesenfeld-Hallin Z; Nilsson S
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10961-5. PubMed ID: 1720557
[TBL] [Abstract][Full Text] [Related]
19. Novel galanin receptor ligands.
Pooga M; Juréus A; Razaei K; Hasanvan H; Saar K; Kask K; Kjellén P; Land T; Halonen J; Mäeorg U; Uri A; Solyom S; Bartfai T; Langel U
J Pept Res; 1998 Jan; 51(1):65-74. PubMed ID: 9495593
[TBL] [Abstract][Full Text] [Related]
20. Galantide improves social memory in rats.
Arletti R; Benelli A; Cavazzuti E; Bertolini A
Pharmacol Res; 1997 Apr; 35(4):317-9. PubMed ID: 9264048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
